Sati Pharma Limited - Due diligence report

A 360° intelligence report on Sati Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress si…

2003-07-08 Mumbai, Maharashtra Strike Off Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sati Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
52/100
Trust Score
Moderate

Sati Pharma Limited is assessed as Moderate with a Trust Score of 52/100. Sati Pharma Limited is a public limited indian non-government company incorporated in 2003, operating in the Home Appliances sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and an unassessed financial risk profile.

Report generated on 17 Oct 2026 from the latest processed filings. Sati Pharma Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
52/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreCaution Indicated
25/100
No active directors on record.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 2 open (3.75 cr) · 1 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Indian Overseas Bank2 48.0 cr
Central Bank Of India1 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • No balance-sheet filing date on record.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 25/100
No active directors on record.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 65
Growth signals & trust indicators
Operating for 23+ years.
Active EPFO - real payroll on record.
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Adverse company status: Strike Off.
Compliance score is weak (38/100).
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence50/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment17/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • 2 open charge(s) of 3.75 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view32/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 5 events
29 Aug 2005
Charge created
Indian Overseas Bank - 2.75 cr
Charge created
Indian Overseas Bank - 1.00 cr
Charge satisfied
Central Bank Of India
18 Nov 2004
Charge created
Central Bank Of India
08 Jul 2003
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Alchemy Urbanventures Private Limited U51101MH2008PTC185461 Mumbai, Maharashtra
Full Frame Media Private Limited U92120MH2009PTC197613 Mumbai, Maharashtra
SHAH DILIPKUMAR LALCHAND TEXTILES LLP AAW-6335 Mumbai, Maharashtra
AMBAVAT JAIN & ASSOCIATES LLP AAA-7120 Mumbai, Maharashtra
Kotwala Enterprise Private Limited U45200MH1989PTC051452 Mumbai, Maharashtra
Blue Vision Cable Network Private Limited U74999MH2016PTC288846 Mumbai, Maharashtra
ADAN TRADERS LLP AAD-8043 Mumbai, Maharashtra
Jaipur Enclave Private Limited U15433MH2005PTC301151 Mumbai, Maharashtra
Goodwill Multitrade Private Limited U51109MH2009PTC194311 Mumbai, Maharashtra
Sumatinath Import And Export Private Limited U74999MH2016PTC282933 Mumbai, Maharashtra
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sati Pharma Limited before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sati Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Sati Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 52/100, distress signals and MSME payment-delay disclosures - know whether Sati Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Sati Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sati Pharma Limited an active company?

Sati Pharma Limited has MCA status “Strike Off” with a compliance score of 38/100 (Caution Indicated).

Is Sati Pharma Limited financially healthy?

Processed financial statements are not yet available for Sati Pharma Limited, so its financial health is unassessed.

Should I do business with Sati Pharma Limited?

Its overall Trust Score is 52/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sati Pharma Limited?

See the directors and ownership sections above for board and shareholding detail.

Does Sati Pharma Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Sati Pharma Limited up to date with its ROC filings?

No balance-sheet filing date on record. Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Sati Pharma Limited?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.